Home LiteratureArticle Details
PMID: 9737282 Published · ppublish English Clinical Trial Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma.

Lancet (London, England) ·Vol. 352 ·No. 9130 ·1998-09-05 ·Pages 772-6

Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA, Teerlink T, Meuwissen SG, Haarman HJ, Thijs LG, van Leeuwen PA

Abstract

Infections are an important cause of morbidity and mortality in patients with multiple trauma. Studies in both animals and human beings have suggested that glutamine-enriched nutrition decreases the number of infections. Patients with multiple trauma with an expected survival of more than 48 h, and who had an Injury Severity Score of 20 or more, were randomly allocated glutamine supplemented enteral nutrition or a balanced, isonitrogenous, isocaloric enteral-feeding regimen along with usual care. Each patient was assessed every 8 h for infection, the primary endpoint. Data were analysed both per protocol, which included enteral feeding for at least 5 days, and by intention to treat. 72 patients were enrolled and 60 received enteral feeding (29 glutamine-supplemented) for at least 5 days. Five (17%) of 29 patients in the glutamine-supplemented group had pneumonia compared with 14 (45%) of 31 patients in the control group (p<0.02). Bacteraemia occurred in two (7%) patients in glutamine group and 13 (42%) in the control group (p<0.005). One patient in the glutamine group had sepsis compared with eight (26%) patients in the control group (p<0.02). There was a low frequency of pneumonia, sepsis, and bacteraemia in patients with multiple trauma who received glutamine-supplemented enteral nutrition. Larger studies are needed to investigate whether glutamine-supplemented enteral nutrition reduces mortality.

MeSH Terms
Adult Aged Arginine/blood Bacteremia/epidemiology Cross Infection/epidemiology Enteral Nutrition/methods Glutamine/administration & dosage,blood Humans Injury Severity Score Length of Stay Middle Aged Multiple Trauma/blood,therapy Pneumonia/epidemiology
Chemicals
Glutamine Arginine
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Houdijk A P
Department of Surgery, Free University Hospital, Amsterdam, Netherlands.
Rijnsburger E R
Jansen J
Wesdorp R I
Weiss J K
McCamish M A
Teerlink T
Meuwissen S G
Haarman H J
Thijs L G
van Leeuwen P A
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
Published
1998-09-05
Pages
772-6
Language
English
Region
England
NLM ID
2985213R
Subset
IM
Corrections
CommentIn
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com